You are now leaving the Kedrion Corporate site. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it.
NO
YES

HIGHLIGHTS

EVENTS

Leading medical-scientific event on Hemophilia held in Trieste, Italy

Kedrion-organized congress put replacement therapy, personalization and access to care in the spotlight

read more 

EVENTS

Kedrion scientific symposium at the 2019 PNS Conference in Genoa, Italy

A chance for world Key Opinion Leaders to debate possible new therapies for the treatment of CIPN

read more 

PLASMA & BIOTHERAPIES

First patient enrolled and treated in Kedrion’s CARES10 clinical study

Phase 3 study to assess efficacy, safety and pharmacokinetics of a 10% IVIg in the treatment of adult PID patients

read more 
  1. EVENTS - 27-04-2018

    Kedrion Biopharma celebrates Primary Immunodeficiency Week

    The company stands alongside PI patients associations around the globe

    read more 
  2. EVENTS - 17-04-2018

    Kedrion Biopharma celebrates World Hemophilia Day 2018

    Support for patients with coagulation disorders worldwide is confirmed

    read more 
  3. EVENTS - 10-04-2018

    50-Year Anniversary of a Maternal Health Breakthrough

    Kedrion Biopharma supports session on Anti-D achievements and challenges at FIGO Congress in Dubai

    read more 
  4. CORPORATE - 16-02-2018

    Kedrion Biopharma runner up at the Premio Equita for the bond issued in July 2017

    The prize is awarded to the companies that made the best use of the capital markets

    read more 

Pages

For more information please contact: pressoffice@kedrion.com